Public COA audit

Triple Agonist

Audited July 28, 2026

Consistent with a legitimate COA

Document structure and test panels align with what we expect from authentic lab reports.

Legitimacy
92
Confidence
88%
Panels
5/7
Purity (printed)
99.79%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR-3XAG10-2605-1
Identity method
HPLC-RTM
Sample date
2026-05-15
Issue date
2026-05-24

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 5 passed · 0 failed · 0 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.79%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Not Detected

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    NMT 0.05 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed with conformity testing

    99.79% purity with three-sample conformity testing (mean 99.30%, std dev 0.3476%). Includes representative chromatogram.

  • Identity confirmed by HPLC-RTM

    Triple Agonist confirmed via chromatographic retention time comparison with reference standard.

  • Complete batch information

    Lot CR-3XAG10-2605-1, COA-2026-DGN4QV, Accession ACC-2026-2645, with access code BOQD4F2C for verification.

  • Dates are consistent and valid

    Received 05/15/2026, analyzed 05/20/2026, issued 05/24/2026. All dates are sequential and on or before 2026-07-28.

  • ISO/IEC 17025 accredited laboratory

    ILS Laboratories, San Diego, CA. Claims ISO/IEC 17025 accreditation. Includes verification URL and QR code.

  • Comprehensive testing panel

    Includes identity, purity, heavy metals (5 elements), sterility (PCR), endotoxin, and fentanyl screen. Missing only microbial count and residual solvents.

  • Additional fentanyl screening

    Immunoassay fentanyl screen (50 ng/mL cutoff) shows Not Detected - unusual but positive safety measure for research peptides.

  • Professional presentation

    Two-page format with detailed methodology notes, conformity testing data, and proper accreditation disclaimers. Signed by Lab Director Dr. Greg Kalyuzhny.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.